학술논문

Enhanced periplasmic expression of human activin A in Escherichia coli using a modified signal peptide.
Document Type
Article
Source
Preparative Biochemistry & Biotechnology. 2020, Vol. 50 Issue 2, p141-147. 7p. 2 Charts, 4 Graphs.
Subject
*ACTIVIN
*ESCHERICHIA coli
*ERYTHROCYTES
*PROTEIN folding
*PROTEIN structure
*BACILLUS licheniformis
*AMYLASES
Language
ISSN
1082-6068
Abstract
Activin A is a member of the transforming growth factor-beta (TGF-β) protein superfamily, which acts as a hormone in regulating cell proliferation and differentiation. Structurally, activin is a dimer of two subunits linked by a disulfide bond. Since the correct folding of this protein is essential for its function, we aimed to use a modified signal peptide to target the expressed recombinant protein to the periplasm of Escherichia coli as an effective strategy to produce correctly-folded activin A. Therefore, the coding sequence of native Iranian Bacillus licheniformis α-amylase signal peptide was modified and its efficiency was checked by SignalP bioinformatics tool. Then its final sequence was cloned upstream of the activin A mature cDNA. Protein expression was done using 1 mM of isopropyl thio-β-D-galactoside (IPTG) and a post-induction time of 8 hr. Additionally, following purification of recombinant activin A, circular dichroism spectroscopy was used to determine the accuracy of secondary structure of the protein. Importantly, differentiation of K562 cells to the red blood cell was confirmed by measuring the amount of Fe+2 ions after treatment with recombinant activin A. The results indicated that the produced recombinant activin A had the same secondary structure as the commercial human activin A and was fully functional. [ABSTRACT FROM AUTHOR]